Literature DB >> 7953393

Interleukin 6 is a prognostic indicator of outcome in severe intra-abdominal sepsis.

R T Patel1, K I Deen, D Youngs, J Warwick, M R Keighley.   

Abstract

Levels of plasma cytokines and circulating endotoxin were assessed in 41 patients with severe intra-abdominal sepsis. Comparison was made with the Acute Physiology And Chronic Health Evaluation (APACHE) II scoring system. Blood samples were taken within 24 h of onset of the sepsis syndrome and at serial times thereafter. Increased levels of interleukin (IL) 6 (range 50-25,500 pg/ml) were detectable in all patients with sepsis. Eighteen of the 19 deaths were attributable to sepsis and higher levels of IL-6 at the onset of the sepsis syndrome correlated with a poor outcome. The sensitivity of IL-6 concentration in predicting mortality was 86.4 per cent with a specificity of 78.9 per cent and an overall correct classification rate of 82.9 per cent. IL-6 level was a better predictor than APACHE II score (sensitivity 72.7 per cent, specificity 57.9 per cent, correct classification rate 65.9 per cent). Levels of tumour necrosis factor alpha, IL-1 beta and endotoxin did not correlate with mortality rate. Plasma IL-6 concentrations may help in planning future strategies to decrease the mortality rate associated with sepsis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7953393     DOI: 10.1002/bjs.1800810914

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  46 in total

Review 1.  Immune therapy in sepsis: Are we ready to try again?

Authors:  Roger Davies; Kieran O'Dea; Anthony Gordon
Journal:  J Intensive Care Soc       Date:  2018-04-04

2.  Use of blood urea nitrogen, creatinine, interleukin-6, granulocyte-macrophage colony stimulating factor in combination to predict the severity and outcome of abdominal sepsis in rats.

Authors:  Min Gao; Lingli Zhang; Ying Liu; Mingshi Yang; Nian Wang; Kangkai Wang; Danmin Ou; Meidong Liu; Guangwen Chen; Ke Liu; Xianzhong Xiao
Journal:  Inflamm Res       Date:  2012-05-29       Impact factor: 4.575

3.  Mannose-binding lectin deficiency influences innate and antigen-presenting functions of blood myeloid dendritic cells.

Authors:  Melinda M Dean; Robert L Flower; Damon P Eisen; Robyn M Minchinton; Derek N J Hart; Slavica Vuckovic
Journal:  Immunology       Date:  2010-11-23       Impact factor: 7.397

4.  Sequential changes in the metabolic response in severely septic patients during the first 23 days after the onset of peritonitis.

Authors:  L D Plank; A B Connolly; G L Hill
Journal:  Ann Surg       Date:  1998-08       Impact factor: 12.969

Review 5.  Management of secondary peritonitis.

Authors:  D H Wittmann; M Schein; R E Condon
Journal:  Ann Surg       Date:  1996-07       Impact factor: 12.969

Review 6.  The significance of endotoxin release in experimental and clinical sepsis in surgical patients--evidence for antibiotic-induced endotoxin release?

Authors:  R G Holzheimer
Journal:  Infection       Date:  1998 Mar-Apr       Impact factor: 3.553

7.  Effects of amniotic membrane on the healing of primary colonic anastomoses in the cecal ligation and puncture model of secondary peritonitis in rats.

Authors:  Mehmet Uludag; Bulent Citgez; Ozay Ozkaya; Gurkan Yetkin; Omer Ozcan; Nedim Polat; Adnan Isgor
Journal:  Int J Colorectal Dis       Date:  2009-01-27       Impact factor: 2.571

Review 8.  Primary and secondary peritonitis: an update.

Authors:  M Laroche; G Harding
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-08       Impact factor: 3.267

9.  Serum IL-6: a candidate biomarker for intracranial pressure elevation following isolated traumatic brain injury.

Authors:  Georgene W Hergenroeder; Anthony N Moore; J Philip McCoy; Leigh Samsel; Norman H Ward; Guy L Clifton; Pramod K Dash
Journal:  J Neuroinflammation       Date:  2010-03-11       Impact factor: 8.322

Review 10.  Sepsis biomarkers: a review.

Authors:  Charalampos Pierrakos; Jean-Louis Vincent
Journal:  Crit Care       Date:  2010-02-09       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.